The Pathologic Substrate of Magnetic Resonance Alterations in Multiple Sclerosis

Neuroimaging Clinics of North America

Volumn 18, Issue 4, 2008, Pages 563-576

  Lassmann, Hans ^a  

^a Medical University of Vienna   (Austria)

Author keywords

Demyelination; Multiple sclerosis; Neurodegeneration; Pathology; Remyelination

Indexed keywords

GADOLINIUM;

ASTROCYTE; AXONAL INJURY; BLOOD BRAIN BARRIER; BRAIN ATROPHY; BRAIN BIOPSY; BRAIN CORTEX; CENTRAL NERVOUS SYSTEM; DEMYELINATING DISEASE; DEMYELINATION; GLIA CELL; GRAY MATTER; HUMAN; INFLAMMATION; LYMPHOCYTE; MACROPHAGE; MULTIPLE SCLEROSIS; MYELIN SHEATH; MYELOOPTIC NEUROPATHY; NERVE FIBER; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REMYELINIZATION; REVIEW;

AXONS; BRAIN; EXTRACELLULAR SPACE; HUMANS; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; NERVE FIBERS, MYELINATED;

EID: 54949147938     PISSN: 10525149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nic.2008.06.005     Document Type: Review

References (104)

1. Babinski J. Recherches sur ĺanatomie pathologique de la sclerose en plaque et etude comparative des diverses varietes de la scleroses de la moelle. Archives de Physiologie (Paris) 5-6 (1885) 186-207
2. e edition (1880), Tome 1, Paris
3. Marburg O. Die sogenannte "akute multiple sklerose". Jahrbücher für Psychiatrie und Neurologie 27 (1906) 211-312
4. Rindfleisch E. Histologisches Detail zur grauen Degeneration von Gehirn und Rückenmark. Arch Pathol. Virchows Archiv 26 (1863) 474-483
5. Doinikow B. Über De- und Regenerationserscheinungen an Achsenzylindern bei der multiplen Sklerose. Zeitschrift für die gesamte Neurologie und Psychiatrie 27 (1915) 151-178
6. Schlesinger H. Zur Frage der akuten multiplen Sklerose und der encephalomyelitis disseminata im Kindesalter. Arbeiten aus dem Neurologischen Institu (Wien) 17 (1909) 410-432
7. Confavreux C., Vukusic S., and Adeleine P. Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain 126 (2003) 770-782
8. Confavreux C., Vukusic S., Moreau T., et al. Relapses and progression of disability in multiple sclerosis. N Engl J Med 343 (2000) 1430-1438
9. Coles A.J., Cox A., Le Page E., et al. The window of therapeutic opportunity in multiple sclerosis. Evidence from monoclonal antibody therapy. J Neurol 253 (2006) 98-108
10. Fu L., Matthews P.M., De-Stefano N., et al. Imaging axonal damage of normal-appearing white matter in multiple sclerosis. Brain 121 (1998) 103-113
11. Leary S.M., Davie C.A., Parker G.J., et al. 1H magnetic resonance spectroscopy of normal appearing white matter in primary progressive multiple sclerosis. J Neurol 246 (1999) 1023-1026
12. De-Stefano N., Narayanan S., Francis S.J., et al. Diffuse axonal and tissue injury in patients with multiple sclerosis with low cerebral lesion load and no disability. Arch Neurol 59 (2002) 1565-1571
13. Rocca M.A., Iannucci G., Rovaris M., et al. Occult tissue damage in patients with primary progressive multiple sclerosis is independent of T2-visible lesions-a diffusion tensor MR study. J Neurol 250 (2003) 456-460
14. Dehmeshki J., Chard D.T., Leary S.M., et al. The normal appearing grey matter in primary progressive multiple sclerosis: a magnetization transfer imaging study. J Neurol 250 (2003) 67-74
15. He J., Inglese M., Li B.S., et al. Relapsing remitting multiple sclerosis; metabolic abnormality in nonenhancing lesions and normal-appearing white matter at MR imaging; initial experience. Radiology 234 (2005) 211-217
16. Filippi M., Rocca M.A., Martino G., et al. Magnetization transfer changes in the normal appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis. Ann Neurol 43 (1998) 809-814
17. Narayanan P.A., Doyle T.J., Lai D., et al. Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis. Ann Neurol 43 (1998) 56-71
18. Lumsden C.E. The neuropathology of multiple sclerosis. In: Vinken P.I., and Bruyn G.W. (Eds). "Handbook of clinical neurology" vol 9 (1970), Elsevier, New York 217-309
19. Lassmann H., Raine C.S., Antel J., et al. Immunopathology of multiple sclerosis: report on an international meeting held at the Institute of Neurology of the University of Vienna. J Neuroimmunol 86 (1998) 213-217
20. Brück W., Porada P., Poser S., et al. Monocyte/macrophage differentiation in early multiple sclerosis lesions. Ann Neurol 38 (1995) 788-796
21. Prineas J.W. The neuropathology of multiple sclerosis. In: Koetsier J.C. (Ed). "Handbook of clinical neurology" vol 47 (1985), Elsevier, New York 337-395
22. Lassmann H. Comparative neuropathology of chronic experimental allergic encephalomyelitis and multiple sclerosis. Springer Schriftenr. Neurol 25 (1983) 1-135
23. De Groot C.J., Bergers E., Kamphorst W., et al. Post-mortem MRI-guided sampling of multiple sclerosis brain lesions: increased yield of active demyelinating and (p)reactive lesions. Brain 124 (2001) 1635-1645
24. Barkhof F., Brück W., De-Groot C.J., et al. Remyelinated lesions in multiple sclerosis: magnetic resonance image appearance. Arch Neurol 60 (2003) 1073-1081
25. Bjartmar C., Kidd G., Mork S., et al. Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients. Ann Neurol 48 (2000) 893-901
26. Ferguson B., Matyszak M.K., Esiri M.M., et al. Axonal damage in acute multiple sclerosis lesions. Brain 120 (1997) 393-399
27. Kornek B., Storch M., Weissert R., et al. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive and remyelinated lesions. Am J Pathol 157 (2000) 267-276
28. Trapp B.D., Peterson J., Ransohoff R.M., et al. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 338 (1998) 278-285
29. Mews I., Bergmann M., Bunkowski S., et al. Oligodendrocyte and axon pathology in clinically silent multiple sclerosis lesions. Mult Scler 4 (1998) 55-62
30. Bitsch A., Kuhlmann T., Stadelmann C., et al. A longitudinal MRI study of histopathologically defined hypointense multiple sclerosis lesions. Ann Neurol 49 (2001) 793-796
31. Van Waesberghe J.H., Kamphorst W., De-Groot C.J., et al. Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol 46 (1999) 747-754
32. Prineas J.W., and Connell F. Remyelination in multiple sclerosis. Ann Neurol 5 (1979) 22-31
33. Prineas J.W., Kwon E.E., Cho E.S., et al. Continual breakdown and regeneration of myelin in progressive multiple sclerosis plaques. Ann N Y Acad Sci 436 (1984) 11-32
34. Prineas J.W., Barnard R.O., Revesz T., et al. Multiple sclerosis. Pathology of recurrent lesions. Brain 116 (1993) 681-693
35. Lucchinetti C., Brück W., Parisi J., et al. A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 117 cases. Brain 122 (1999) 2279-2295
36. Prineas J.W., Kwon E.E., Goldenberg P.Z., et al. Multiple sclerosis. Oligodendrocyte proliferation and differentiation in fresh lesions. Lab Invest 61 (1989) 489-503
37. Raine C.S., Scheinberg L., and Waltz J.M. Multiple sclerosis: Oligodendrocyte survival and proliferation in an active established lesion. Lab Invest 45 (1981) 534-546
38. Prineas J.W., Barnard R.O., Kwon E.E., et al. Multiple sclerosis: remyelination of nascent lesions. Ann Neurol 33 (1993) 137-151
39. Patrikios P., Stadelmann C., Kutzelnigg A., et al. Remyelination is extensive in a subset of multiple sclerosis patients. Brain 129 (2006) 3165-3172
40. Patani R., Balaratnam M., Vora A., et al. Remyelination can be extensive in multiple sclerosis despite a long disease course. Neuropathol Appl Neurobiol 33 (2007) 277-287
41. Chen J.T., Kuhlmann T., Jansen G.H., et al., Canadian MS/BMT Stdy Group. Voxel-based analysis of the evolution of magnetization transfer ratio to quantify remyelination and demyelination with histopathological validation in a multiple sclerosis lesion. Neuroimage 36 (2007) 1152-1158
42. Minneboo A., Uitdenhaag B.M., Ader H.J., et al. Patterns of enhancing lesion evolution in multiple sclerosis are uniform within patients. Neurology 65 (2005) 56-61
43. Miller D.H., Rudge P., Johnson G., et al. Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis. Brain 111 (1988) 927-939
44. Grossman R.I., Braffman B.H., Brorson J.R., et al. Multiple sclerosis: serial study of gadolinium enhanced MR imaging. Radiology 169 (1988) 117-122
45. Kappos L., Moeri D., Radue E.W., et al. For the gadolinium MRI meta-analysis group. Predictive value of gadolinium-enhancement magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Lancet 353 (1999) 964-969
46. Brück W., Bitsch A., Kolenda H., et al. Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology. Ann Neurol 42 (1997) 783-793
47. Katz D., Taubenberger J.K., Cannella B., et al. Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis. Ann Neurol 34 (1993) 661-669
48. Broman T. Blood brain barrier damage in multiple sclerosis. Supra-vital test observations. Acta Neurol Scand 10 (1964) 21-24
49. Kwon E.E., and Prineas J.W. Blood brain barrier abnormalities in longstanding multiple sclerosis lesions. An immunohistochemical study. J Neuropathol Exp Neurol 53 (1994) 625-636
50. Claudio L., Raine C.S., and Brosnan C.F. Evidence for persistent blood-brain barrier abnormalities in chronic-progressive multiple sclerosis. Acta Neuropathol 90 (1995) 228-238
51. Vos C.M., Geurts J.J., Montagne L., et al. Blood brain barrier alterations in both focal and diffuse abnormalities on postmortem MRI in multiple sclerosis. Neurobiol Dis 20 (2005) 953-960
52. Kirk J., Plumb J., Mirakhur M., et al. Tight junctional abnormality in multiple sclerosis white matter affects all calibers of vessel and is associated with blood-brain barrier leakage and active demyelination. J Pathol 201 (2003) 319-327
53. Hochmeister S., Grundtner R., Bauer J., et al. Dysferlin is a new marker for leaky brain blood vessels in multiple sclerosis. J Neuropathol Exp Neurol 65 (2006) 855-865
54. Ingle G.T., Sastre-Garriga J., Miller D.H., et al. Is inflammation important in early PPMS? A longitudinal MRI study. J Neurol Neurosurg Psychiatr 76 (2008) 1255-1258
55. Kutzelnigg A., Lucchinetti C.F., Stadelmann C., et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 128 (2005) 2705-2712
56. Serafini B., Rosicarelli B., Magliozzi R., et al. Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. Brain Pathol 14 (2004) 164-174
57. Breij E.C., Brink B.P., Veerhuis R., et al. Homogeneity of active demyelinating lesions in established multiple sclerosis. Ann Neurol 63 (2008) 16-25
58. Newcombe J., Hawkins C.P., Henderson C.L., et al. Histopathology of multiple sclerosis lesions detected by magnetic resonance imaging in unfixed post-mortem central nervous system tissue. Brain 114 (1991) 1013-1023
59. Prineas J.W., Kwon E.E., Cho E.S., et al. Immunopathology of secondary-progressive multiple sclerosis. Ann Neurol 50 (2001) 646-657
60. Cotton F., Weiner H.L., Jolesz F.A., et al. MRI contrast uptake in new lesions in relapsing-remitting MS followed at weekly intervals. Neurology 60 (2003) 640-646
61. Barnett M.H., and Prineas J.W. Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol 55 (2004) 458-468
62. Marik C., Felts P., Bauer J., et al. Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity?. Brain 130 (2007) 2800-2815
63. Lucchinetti C., Brück W., Parisi J., et al. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47 (2000) 707-717
64. De-Stefano N., Narayanan S., Matthews P.M., et al. In vivo evidence for axonal dysfunction remote from focal cerebral demyelination of the type seen in multiple sclerosis. Brain 122 (1999) 1933-1939
65. Rovaris M., Bozzali M., Santuccio G., et al. In vivo assessment of the brain and cervical cord pathology of patients with primary progressive multiple sclerosis. Brain 124 (2001) 2540-2549
66. Pelletier D., Nelson S.J., Oh J., et al. MRI lesion volume heterogeneity in primary progressive MS in relation with axonal damage and brain atrophy. J Neurol Neurosurg Psychiatr 74 (2003) 950-952
67. Peterson J.W., Bo L., Mork S., et al. Transsected neurites, apoptotic neurons and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 50 (2001) 389-400
68. Wegner C., Esiri M.M., Chance S.A., et al. Neocortical neuronal, synaptic and glial loss in multiple sclerosis. Neurology 67 (2006) 960-967
69. Evangelou N., Konz D., Esiri M.M., et al. Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis. Brain 123 (2000) 1845-1849
70. Ganter P., Prince C., and Esiri M.M. Spinal cord axonal loss in multiple sclerosis: a post-mortem study. Neuropathol Appl Neurobiol 25 (1999) 459-467
71. Lovas G., Szilagyi N., Majtenyi K., et al. Axonal changes in chronic demyelinated cervical spinal cord plaques. Brain 123 (2000) 308-317
72. Evangelou N., DeLuca G.C., Owens T., et al. Pathological study of spinal cord atrophy in multiple sclerosis suggests limited role of focal lesions. Brain 128 (2005) 29-34
73. De Luca G.C., Williams K., Evangelou N., et al. The contribution of demyelination to axonal loss in multiple sclerosis. Brain 129 (2006) 1507-1516
74. Allen IV, and McKeown S.R. A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis. J Neurol Sci 41 (1979) 81-91
75. Allen IV, McQuid S., Miradkhur M., et al. Pathological abnormalities in the normal-appearing white matter in multiple sclerosis. Neurol Sci 22 (2001) 141-144
76. Brownell B., and Hughes J.T. The distribution of plaques in the cerebrum in multiple scleosis. J Neurol Neurosurg Psychiatr 25 (1962) 315-320
77. Gilmore C.P., Bo L., Owens T., et al. Spinal cord grey matter demyelination in multiple sclerosis: a novel pattern of residual plaque morphology. Brain Pathol 16 (2006) 202-208
78. Khaleeli Z., Cercignani M., Audoin B., et al. Localized grea matter damage in early primary progressive multiple sclerosis contributes to disability. Neuroimage 37 (2007) 253-261
79. Bo L., Vedeler C.A., Nyland H.I., et al. Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J Neuropathol Exp Neurol 62 (2003) 723-732
80. Kidd T., Barkhof F., McConnell R., et al. Cortical lesions in multiple sclerosis. Brain 122 (1999) 17-26
81. Kutzelnigg A., and Lassmann H. Cortical demyelination in multiple sclerosis: a substrate for cognitive deficits?. J Neurol Sci 245 (2006) 123-126
82. Kutzelnigg A., Faber-Rod J.C., Bauer J., et al. Widespread demyelination in the cerebellar cortex in multiple sclerosis. Brain Pathol 17 (2007) 38-44
83. Geurts J.J., Bo L., Roosendaal S.D., et al. Extensive hippocampal demyelination in multiple sclerosis. J Neuropathol Exp Neurol 66 (2007) 819-827
84. Moll N.M., Rietsch A.M., Ransohoff A.J., et al. Cortical demyelination in PML and MS: similarities and differences. Neurology 70 (2007) 336-343
85. Bo L., Vedeler C.A., Nyland H., et al. Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration. Mult Scler 9 (2003) 323-331
86. Magliozzi R., Howell O., Vora A., et al. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain 130 (2007) 1089-1104
87. Van Horssen J., Brink B.P., de Vries H.E., et al. The blood brain barrier in cortical multiple sclerosis lesions. J Neuropathol Exp Neurol 66 (2007) 321-328
88. Vercellino M., Plano F., Votta B., et al. Grey matter pathology in multiple sclerosis. J Neuropathol Exp Neurol 64 (2005) 1101-1107
89. Albert M., Antel J., Brück W., et al. Extensive cortical remyelination in patients with chronic multiple sclerosis. Brain Pathol 17 (2007) 129-138
90. Geurts J.J., Bo L., Pouwels P.J., et al. Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology. ANJR Am J Neuroradiol 26 (2005) 572-577
91. Geurts J.J., Blezer E.L., Vrenken H., et al. Does high-field MR imaging improve cortical lesion detection in multiple sclerosis?. J Neurol 255 (2008) 183-191
92. Kangariu A., Bourekas E.C., Ray-Chaudhury A., et al. Cerebral cortical lesions detected by MR imaging at 8 Tesla. Amer J Neuroradiol 28 (2007) 262-266
93. Dal Bianco A., Bradl M., Frischer J., et al. Multiple sclerosis and Alzheimer's disease. Ann Neurol 63 (2008) 174-183
94. Wingerchuck D.M., Lennon V.A., Pittock S.J., et al. Revised diagnostic criteria for neuromyelitis optica. Neurology 66 (2006) 1485-1489
95. Devic E. Myelite subaigue compliquee de nevrite optique. Bull Med 8 (1984) 1033
96. Weinshenker B.G., Wingerchuk D.M., Vukusic S., et al. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol 59 (2006) 566-569
97. Fog T. Topographic distribution of plaques in the spinal cord in multiple sclerosis. Arch Neurol Psychiat 63 (1950) 382-414
98. Roemer S.F., Parisi J.E., Lennon V.A., et al. Distinct pattern of aquaporin-4 expression in neuromyelitis optica lesions. Brain 130 (2007) 1194-1205
99. Lennon V.A., Wingerchuk D.N., Kryzer T.J., et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364 (2004) 2106-2112
100. Lennon V.A., Kryzer T.J., Pittock S.J., et al. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202 (2005) 473-477
101. Pittock S.J., Weinshenker B.G., Lucchinetti C.F., et al. Neuromyelitis optica brain lesions localized at sites of high aquaporin-4 expression. Arch Neurol 63 (2006) 964-968
102. Lucchinetti C.F., Mandler R., McGavern D., et al. A role for humoral mechanisms in he pathogenesis of Devic's neuromyelitis optica. Brain 125 (2002) 1450-1461
103. Balo J. Encephalitis periaxialis concentrica. Arch Neurol 19 (1928) 242-264
104. Stadelmann C., Ludwin S., Tabira T., et al. Tissue preconditioning may explain concentric lesions in Balo's type of multiple sclerosis. Brain 128 (2005) 979-987